Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery.

We have examined the complement-activating properties of synthetic cationic molecules and their complexes with DNA. Commonly used gene delivery vehicles include complexes of DNA with polylysine of various chain lengths, transferrin-polylysine, a fifth-generation poly(amidoamine) (PAMAM) dendrimer, poly(ethyleneimine), and several cationic lipids (DOTAP, DC-Chol/DOPE, DOGS/DOPE, and DOTMA/DOPE). These agents activate the complement system to varying extents. Strong complement activation is seen with long-chain polylysines, the dendrimer, poly(ethyleneimine), and DOGS (half-maximal at about 3 microM amine content in the assay used). Compared to these compounds, the other cationic lipids (in liposome formulations) are weak activators of the complement system (half-maximal approximately 50-100 microM positive charge in assay). Complement activation by polylysine is strongly dependent on the chain length. Short-chain oligolysines are comparable to cationic lipids in their activation of complement. Incubation of these compounds with DNA to form complexes reduces complement activation in virtually all cases. The degree of complement activation by DNA complexes is strongly dependent on the ratio of polycation and DNA (expressed as the charge ratio) for polylysine, dendrimer, poly(ethyleneimine), and DOGS. To a lesser degree, charge ratio also influences complement activation by monovalent cationic lipid-DNA complexes. For polylysine-DNA complexes, complement activation can be considerably reduced by modifying the surface of preformed DNA complexes with polyethyleneglycol (half-maximal approximately 20 microM amine content). The data suggests that, by appropriate formulation of DNA complexes, complement activation can be minimized or even avoided. These findings should facilitate the search for DNA complex formulations appropriate for reproducible intravenous gene delivery.

[1]  M. Hashida,et al.  Physicochemical and pharmacokinetic characteristics of plasmid DNA/cationic liposome complexes. , 1995, Journal of pharmaceutical sciences.

[2]  D. Liggitt,et al.  Cationic Liposome-mediated Intravenous Gene Delivery (*) , 1995, The Journal of Biological Chemistry.

[3]  C. Y. Chow,et al.  A novel series of amphiphilic imidazolinium compounds for in vitro and in vivo gene delivery. , 1995, Biochemistry.

[4]  L. Mahan,et al.  Systemic gene therapy: biodistribution and long-term expression of a transgene in mice. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A. Miller,et al.  Gene delivery and expression mediated by an integrin-binding peptide. , 1995, Gene therapy.

[6]  S. Varsano,et al.  Expression and distribution of cell-membrane complement regulatory glycoproteins along the human respiratory tract. , 1995, American journal of respiratory and critical care medicine.

[7]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[8]  K. Rice,et al.  Targeted gene delivery with a low molecular weight glycopeptide carrier. , 1995, Bioconjugate chemistry.

[9]  I. Wicks,et al.  Bacterial lipopolysaccharide copurifies with plasmid DNA: implications for animal models and human gene therapy. , 1995, Human gene therapy.

[10]  J. C. Perales,et al.  Gene transfer into the airway epithelium of animals by targeting the polymeric immunoglobulin receptor. , 1995, The Journal of clinical investigation.

[11]  C. Wu,et al.  Overexpression of human methylmalonyl CoA mutase in mice after in vivo gene transfer with asialoglycoprotein/polylysine/DNA complexes. , 1994, Human gene therapy.

[12]  J. Behr,et al.  Gene transfer with synthetic cationic amphiphiles: prospects for gene therapy. , 1994, Bioconjugate chemistry.

[13]  B. Meyrick,et al.  No lung toxicity after repeated aerosol or intravenous delivery of plasmid-cationic liposome complexes. , 1994, Journal of applied physiology.

[14]  M. Cotten,et al.  Lipopolysaccharide is a frequent contaminant of plasmid DNA preparations and can be toxic to primary human cells in the presence of adenovirus. , 1994, Gene therapy.

[15]  J. Wilson,et al.  In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. , 1994, The Journal of biological chemistry.

[16]  J. C. Perales,et al.  Gene transfer in vivo: sustained expression and regulation of genes introduced into the liver by receptor-targeted uptake. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Matthew Cotten,et al.  Delivery of drugs, proteins and genes into cells using transferrin as a ligand for receptor-mediated endocytosis , 1994 .

[18]  B. Meyrick,et al.  Protection of rabbit lungs from endotoxin injury by in vivo hyperexpression of the prostaglandin G/H synthase gene. , 1994, The Journal of clinical investigation.

[19]  M. Cotten,et al.  Non-viral approaches to gene therapy. , 1993, Current opinion in biotechnology.

[20]  Catherine H. Wu,et al.  Liver-directed gene delivery , 1993 .

[21]  P. Davis,et al.  Gene transfer into respiratory epithelial cells by targeting the polymeric immunoglobulin receptor. , 1993, The Journal of clinical investigation.

[22]  C. Alving,et al.  Complement-dependent phagocytosis of liposomes. , 1993, Chemistry and physics of lipids.

[23]  F. Szoka,et al.  Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. , 1993, Bioconjugate chemistry.

[24]  S. Tomlinson Complement defense mechanisms. , 1993, Current opinion in immunology.

[25]  H. Gewurz,et al.  DNA binds and activates complement via residues 14-26 of the human C1q A chain. , 1992, The Journal of biological chemistry.

[26]  M. Woodle,et al.  Sterically stabilized liposomes. , 1992, Biochimica et biophysica acta.

[27]  S. Thorgeirsson,et al.  Adenovirus–mediated in vivo gene transfer and expression in normal rat liver , 1992, Nature Genetics.

[28]  J H Senior,et al.  Interaction of positively-charged liposomes with blood: implications for their application in vivo. , 1991, Biochimica et biophysica acta.

[29]  M. Cotten,et al.  Adenovirus enhancement of transferrin-polylysine-mediated gene delivery. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[30]  J. Wilson,et al.  Receptor-mediated gene delivery in vivo. Partial correction of genetic analbuminemia in Nagase rats. , 1991, The Journal of biological chemistry.

[31]  K. Mechtler,et al.  DNA-binding transferrin conjugates as functional gene-delivery agents: synthesis by linkage of polylysine or ethidium homodimer to the transferrin carbohydrate moiety. , 1991, Bioconjugate chemistry.

[32]  D. Devine,et al.  The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes. , 1991, Journal of immunology.

[33]  G. Matyas,et al.  Complement-dependent phagocytosis of liposomes by macrophages: suppressive effects of "stealth" lipids. , 1991, Biochemical and biophysical research communications.

[34]  G Blume,et al.  Liposomes for the sustained drug release in vivo. , 1990, Biochimica et biophysica acta.

[35]  H. Lim The complement system. Activation, modulation, and clinical relevance. , 1990, Dermatologic clinics.

[36]  M. Cotten,et al.  Transferrin-polycation conjugates as carriers for DNA uptake into cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. Cotten,et al.  Receptor-mediated endocytosis of transferrin-polycation conjugates: an efficient way to introduce DNA into hematopoietic cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[38]  M. Mannik,et al.  The location of binding sites on C1q for DNA. , 1990, Journal of immunology.

[39]  T. Yokochi,et al.  Strong interaction of lipopolysaccharides possessing the mannose homopolysaccharides with complement and its relation to adjuvant action. , 1990, Journal of immunology.

[40]  James M. Wilson,et al.  Targeting genes: delivery and persistent expression of a foreign gene driven by mammalian regulatory elements in vivo. , 1989, The Journal of biological chemistry.

[41]  J. Behr,et al.  Efficient gene transfer into mammalian primary endocrine cells with lipopolyamine-coated DNA. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[42]  B. Meyrick,et al.  Expression of a prokaryotic gene in cultured lung endothelial cells after lipofection with a plasmid vector. , 1989, American journal of respiratory cell and molecular biology.

[43]  C. Wu,et al.  Receptor-mediated gene delivery and expression in vivo. , 1988, The Journal of biological chemistry.

[44]  R. Dwek,et al.  Interaction of Clq with DNA , 1982 .

[45]  H. Gewurz,et al.  Complement activation by interaction of polyanions and polycations. , 1975, Immunology.

[46]  R. Winchester,et al.  Precipitin reactions of the C1q component of complement with aggregated gamma-globulin and immune complexes in gel diffusion. , 1970, Immunology.

[47]  K. Mechtler,et al.  COMPLEMENT ACTIVATION BY POLYLYSINE-DNA COMPLEXES , 1996 .

[48]  M. Hashida,et al.  In vivo disposition characteristics of plasmid DNA complexed with cationic liposomes. , 1995, Journal of drug targeting.

[49]  N. Cooper The classical complement pathway: activation and regulation of the first complement component. , 1985, Advances in immunology.

[50]  James R. Dewald,et al.  A New Class of Polymers: Starburst-Dendritic Macromolecules , 1985 .

[51]  H. van Dijk,et al.  Microassay for colorimetric estimation of complement activity in guinea pig, human and mouse serum. , 1983, Journal of immunological methods.